Tag: Research
-
Study Shows Cell Membrane-Bound Enzyme is Essential for COVID-19 Infection
The membrane-bound form of the ACE2 protein is the essential receptor for enabling COVID-19 infectivity, according to a Northwestern Medicine study.
-
Feinberg Announces 2022 Mentors of the Year
Feinberg’s Medical Faculty Council recently honored the recipients of the 2022 Mentor of the Year award at a virtual mentoring workshop.
-
Accelerating Cancer Immunology and Immunotherapy Research
The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.
-
Understanding Immunosuppressive Mechanisms of T-Cell Receptors
Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.
-
Most COVID-19 ‘Long Haulers’ Continue to Experience Symptoms 15 Months After Initial Infection
Most non-hospitalized COVID-19 “long-haulers” at the Northwestern Medicine Neuro COVID-19 Clinic continued to experience symptoms including brain fog, dizziness and fatigue 15 months after disease onset, according to a new study.
-
Blood Test Predicts Response to Immunotherapy
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
-
Study Identifies New Therapeutic Target for Most Common Type of Pancreatic Cancer
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
-
Student Investigates Private Equity in Dermatology
Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.
-
Recurring Brain Tumor Growth is Halted with New Drug
A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
-
New Regulator of Therapy Resistance in Prostate Cancer
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
